← All organizations

Midatech Pharma

For profitWebsite ↗

Also known as: FORTOVIA | Midatech Pharma | MIDATECH PHARMA US | Midatech Pharma US Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Apr 30, 2020

Timeline

2000s

Jun 1, 2000
Midatech Pharma— Founded

2010s

Apr 16, 2010
miconazole— Marketing Organization
Apr 16, 2010
miconazole— NDA Secondary Org
Jun 1, 2015
DARA Therapeutics— Acquired

Drugs by trial phase (14 distinct, 12 trials)

Phase 4 (5 own, 0 via acquisition)

Phase 3 (0 own, 3 via acquisition)

Phase 2 (1 own, 4 via acquisition)

Phase 1 (1 own, 0 via acquisition)

motexafin gadolinium

Indications

Studied for

Marketed drugs (3)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (5)

NCT04264143CollaboratorPhase 1Apr 30, 2020
NCT04315064CollaboratorEarly Phase 1Mar 19, 2020
NCT03566199CollaboratorPhase 1/Phase 2May 22, 2018
NCT03490396Study directorPhase 4May 15, 2018
NCT03490396Lead sponsorPhase 4May 15, 2018

Details

Founded: Cardiff, GB Jun 1, 2000
Last known activity: Apr 30, 2020